Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
Translational Oncology
|
January 28, 2014
Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
Nadine Löschmann, Martin Michaelis, Florian Rothweiler, et al.
Cancers
|
November 25, 2020
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
Ana Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status
Frank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Nature Cell Biology
|
February 23, 2010
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma, Jennifer Young, Harsha Prabhala, et al.
Science Signaling
|
December 24, 2015
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey, Melinda Halasz, Daniel Dreidax, et al.
Molecular Oncology
|
November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Fakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
BMC Genomics
|
September 24, 2004
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Qing-Rong Chen, Sven Bilke, Jun S Wei, et al.
Life Science Alliance
|
July 31, 2023
Exploring the impact of dexamethasone on gene regulation in myeloma cells
Victor Bessonneau-Gaborit, Jonathan Cruard, Catherine Guerin-Charbonnel, et al.
Ebiomedicine
|
December 9, 2022
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma
Ferdinando Bonfiglio, Vito Alessandro Lasorsa, Sueva Cantalupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
FOXR2 Stabilizes MYCN Protein and Identifies Non-<i>MYCN</i>-Amplified Neuroblastoma Patients With Unfavorable Outcome
Felix Schmitt-Hoffner, Sjoerd van Rijn, Umut H Toprak, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
Translational Oncology
|
January 28, 2014
Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
Nadine Löschmann, Martin Michaelis, Florian Rothweiler, et al.
Cancers
|
November 25, 2020
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
Ana Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status
Frank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Nature Cell Biology
|
February 23, 2010
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma, Jennifer Young, Harsha Prabhala, et al.
Science Signaling
|
December 24, 2015
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
Dirk Fey, Melinda Halasz, Daniel Dreidax, et al.
Molecular Oncology
|
November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Fakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
BMC Genomics
|
September 24, 2004
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Qing-Rong Chen, Sven Bilke, Jun S Wei, et al.
Life Science Alliance
|
July 31, 2023
Exploring the impact of dexamethasone on gene regulation in myeloma cells
Victor Bessonneau-Gaborit, Jonathan Cruard, Catherine Guerin-Charbonnel, et al.
Ebiomedicine
|
December 9, 2022
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma
Ferdinando Bonfiglio, Vito Alessandro Lasorsa, Sueva Cantalupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
FOXR2 Stabilizes MYCN Protein and Identifies Non-<i>MYCN</i>-Amplified Neuroblastoma Patients With Unfavorable Outcome
Felix Schmitt-Hoffner, Sjoerd van Rijn, Umut H Toprak, et al.
Page
of 14